1,6-二磷酸果糖治疗小儿病毒性心肌炎临床疗效观察

摘要

目的 观察1,6-二磷酸果糖治疗小儿病毒性心肌炎的临床效果.方法 将122例病毒性心肌炎的患儿随机抽签分治疗组60例及对照组62例,治疗组应用1,6-二磷酸果糖,对照组应用能量合剂.结果 治疗组总有效52例(86.7%),优于对照组42例(67.7%);治疗组合并早搏的患儿减少早搏总有效16例(88.9%),优于对照组19例(70.4%),2组差异有统计学意义(P<0.05).结论 1,6-二磷酸果糖治疗小儿病毒性心肌炎有明显疗效,值得临床应用.%Objectives To investigate the curative effect of Fructose-1, 6-diphosphate on pedo-viral myo-carditis. Methods Sixty patients in the treatment group had Fructose-1, 6-diphosphate and conventional therapy.62 patients in the control group were only treated with conventional therapy. Results The total effective rate of treatment group(86.7%) was higher than that of control group(67.7%). Fructose-1,6-diphosphate increased the effective rate, decreased the myo-creatase and improved the clinical symptoms. Conclusions Fructose-1, 6-diphosphate is effective for treating pedo-viral myocarditis.